HKD 20.45
(-2.39%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 957.06 Million CNY | -58.59% |
2022 | 2.31 Billion CNY | 158.64% |
2021 | 893.69 Million CNY | 202.12% |
2020 | 295.8 Million CNY | -23.15% |
2019 | 384.9 Million CNY | 27.8% |
2018 | 301.18 Million CNY | 40.19% |
2017 | 214.84 Million CNY | 23.66% |
2016 | 173.73 Million CNY | 43.31% |
2015 | 121.23 Million CNY | 35.89% |
2014 | 89.21 Million CNY | 24.49% |
2013 | 71.66 Million CNY | 20.6% |
2012 | 59.42 Million CNY | 32.69% |
2011 | 44.78 Million CNY | 42.01% |
2010 | 31.53 Million CNY | 60.14% |
2009 | 19.69 Million CNY | -5.38% |
2008 | 20.81 Million CNY | 42.93% |
2007 | 14.56 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 495.72 Million CNY | 153.81% |
2024 Q2 | 376.86 Million CNY | 147.96% |
2023 Q4 | 195.31 Million CNY | 0.4% |
2023 FY | 957.06 Million CNY | -58.59% |
2023 Q1 | 549.54 Million CNY | -14.32% |
2023 Q2 | 17.67 Million CNY | -96.78% |
2023 Q3 | 194.53 Million CNY | 1000.32% |
2022 Q4 | 641.41 Million CNY | -6.99% |
2022 FY | 2.31 Billion CNY | 158.64% |
2022 Q1 | 452.32 Million CNY | 26.44% |
2022 Q2 | 528.08 Million CNY | 16.75% |
2022 Q3 | 689.64 Million CNY | 30.59% |
2021 Q3 | 303.9 Million CNY | 105.19% |
2021 Q4 | 357.74 Million CNY | 17.71% |
2021 FY | 893.69 Million CNY | 202.12% |
2021 Q1 | 83.93 Million CNY | -34.2% |
2021 Q2 | 148.11 Million CNY | 76.46% |
2020 Q3 | 66.37 Million CNY | 57.26% |
2020 Q2 | 42.2 Million CNY | -29.26% |
2020 Q1 | 59.66 Million CNY | 5.08% |
2020 FY | 295.8 Million CNY | -23.15% |
2020 Q4 | 127.56 Million CNY | 92.19% |
2019 Q1 | 68.62 Million CNY | -54.3% |
2019 Q4 | 56.77 Million CNY | -22.48% |
2019 Q3 | 73.24 Million CNY | -60.67% |
2019 FY | 384.9 Million CNY | 27.8% |
2019 Q2 | 186.25 Million CNY | 171.41% |
2018 Q1 | 53.01 Million CNY | -50.56% |
2018 Q4 | 150.15 Million CNY | 180.34% |
2018 FY | 301.18 Million CNY | 40.19% |
2018 Q3 | 53.56 Million CNY | 20.48% |
2018 Q2 | 44.45 Million CNY | -16.15% |
2017 Q1 | 41.23 Million CNY | -32.01% |
2017 FY | 214.84 Million CNY | 23.66% |
2017 Q4 | 107.22 Million CNY | 95.68% |
2017 Q3 | 54.79 Million CNY | 373.03% |
2017 Q2 | 11.58 Million CNY | -71.91% |
2016 FY | 173.73 Million CNY | 43.31% |
2016 Q4 | 60.65 Million CNY | 52.97% |
2016 Q3 | 39.64 Million CNY | -12.65% |
2016 Q1 | 28.04 Million CNY | -36.36% |
2016 Q2 | 45.39 Million CNY | 61.88% |
2015 Q4 | 44.05 Million CNY | 39.14% |
2015 Q1 | 18.6 Million CNY | -28.51% |
2015 Q2 | 26.9 Million CNY | 44.59% |
2015 Q3 | 31.66 Million CNY | 17.71% |
2015 FY | 121.23 Million CNY | 35.89% |
2014 Q1 | 17.25 Million CNY | -3.14% |
2014 Q4 | 26.02 Million CNY | 10.51% |
2014 Q3 | 23.54 Million CNY | 5.18% |
2014 Q2 | 22.38 Million CNY | 29.76% |
2014 FY | 89.21 Million CNY | 24.49% |
2013 Q3 | 18.97 Million CNY | 2.2% |
2013 FY | 71.66 Million CNY | 20.6% |
2013 Q1 | 16.31 Million CNY | -10.99% |
2013 Q2 | 18.56 Million CNY | 13.82% |
2013 Q4 | 17.81 Million CNY | -6.12% |
2012 Q3 | 12.71 Million CNY | -17.53% |
2012 FY | 59.42 Million CNY | 32.69% |
2012 Q1 | 12.97 Million CNY | -20.7% |
2012 Q2 | 15.41 Million CNY | 18.82% |
2012 Q4 | 18.32 Million CNY | 44.17% |
2011 Q2 | 9.92 Million CNY | 57.81% |
2011 FY | 44.78 Million CNY | 42.01% |
2011 Q4 | 16.35 Million CNY | 33.99% |
2011 Q3 | 12.2 Million CNY | 22.98% |
2011 Q1 | 6.29 Million CNY | -56.69% |
2010 Q1 | 4.13 Million CNY | -22.93% |
2010 FY | 31.53 Million CNY | 60.14% |
2010 Q4 | 14.52 Million CNY | 114.56% |
2010 Q3 | 6.76 Million CNY | 10.93% |
2010 Q2 | 6.1 Million CNY | 47.5% |
2009 Q3 | 5.19 Million CNY | 0.0% |
2009 Q4 | 5.36 Million CNY | 3.28% |
2009 FY | 19.69 Million CNY | -5.38% |
2008 FY | 20.81 Million CNY | 42.93% |
2007 FY | 14.56 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 35.87 Million HKD | -2567.861% |
Lee & Man Chemical Company Limited | 588.88 Million HKD | -62.522% |